Esorubicin (deoxydoxorubicin) has low grade activity in malignant melanoma. Results of an Eastern Cooperative Oncology Group study (EST 2685).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples